| Followers | 196 |
| Posts | 13482 |
| Boards Moderated | 0 |
| Alias Born | 06/20/2022 |
Thursday, June 06, 2024 12:30:55 PM
FBLG: Well then, Lord-SMARTER-Fellow, of the King's Royal Guard!!! CONGRATS to ya!! (Seriously!!) How long were ya holdin' this puppy, Dude???
This is my Girl Friend's FAVORITE song!! (She's a Music Major over here in San Diego State):
This is my Girl Friend's FAVORITE song!! (She's a Music Major over here in San Diego State):
Bullish
Recent FBLG News
- FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting • GlobeNewswire Inc. • 05/22/2026 12:30:00 PM
- FibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics • GlobeNewswire Inc. • 05/18/2026 12:30:00 PM
- FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:02:30 AM
- FibroBiologics CEO Issues Letter to Shareholders • GlobeNewswire Inc. • 05/05/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 11:21:21 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/05/2026 11:19:30 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/05/2026 11:18:51 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/05/2026 11:18:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 11:00:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 11:00:19 PM
- FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring • GlobeNewswire Inc. • 05/04/2026 08:01:00 PM
- FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial • GlobeNewswire Inc. • 05/04/2026 12:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/01/2026 08:03:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:01:24 PM
- FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/30/2026 09:55:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/30/2026 09:19:54 PM
- FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026 • GlobeNewswire Inc. • 04/30/2026 12:30:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/22/2026 08:34:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 08:15:22 PM
- FibroBiologics Compliant with All Nasdaq Listing Requirements • GlobeNewswire Inc. • 04/20/2026 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 08:05:15 PM
- FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity • GlobeNewswire Inc. • 04/10/2026 12:30:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/09/2026 09:20:28 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/09/2026 08:30:14 PM
